help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asselin, E.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asselin, E.
Right arrow Articles by Tsang, B. K.
Endocrinology Vol. 142, No. 6 2451-2457
Copyright © 2001 by The Endocrine Society


ARTICLES

X-Linked Inhibitor of Apoptosis Protein Activates the Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Granulosa Cells during Follicular Development1

Eric Asselin2, Yifang Wang and Benjamin K. Tsang

Reproductive Biology Unit and Division of Reproductive Medicine, Departments of Obstetrics and Gynecology and Cellular and Molecular Medicine, University of Ottawa; and Ottawa Health Research Institute, The Ottawa Hospital (Civic Campus), Ottawa, Ontario, Canada K1Y 4E9

Address all correspondence and requests for reprints to: Benjamin K. Tsang, Ph.D., Ottawa Health Research Institute, The Ottawa Hospital (Civic Campus), 725 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 4E9. E-mail: btsang{at}lri.ca


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
X-linked inhibitor of apoptosis protein (XIAP) in granulosa cells is regulated by gonadotropins during follicular development, although the current understanding of the mechanisms by which XIAP suppressed granulosa cell apoptosis is incomplete. In the present study, we investigated the possible involvement of the phosphatidylinositol 3-kinase (PI 3-K) survival pathway in the regulation of granulosa cell fate. Using a fully characterized in vivo model to study the induction of follicular development and atresia in immature rats, we have demonstrated that gonadotropin treatment increased granulosa cell XIAP and phospho-Akt protein contents and suppressed apoptosis. In addition, gonadotropin withdrawal [equine CG (eCG)-primed rats treated with an anti-eCG antibody] induced granulosa cell apoptosis and significantly decreased ovarian weight. The increased apoptosis was accompanied by marked decreases in XIAP expression and phosphorylation of Akt protein. Infection of granulosa cells from eCG-primed rats with adenoviral sense XIAP [lacZ as a control; multiplicity of infection, 1–5] resulted in XIAP overexpression and increased phospho-Akt content, whereas XIAP antisense expression (multiplicity of infection, 10–40) decreased granulosa cell phospho-Akt level and induced apoptosis. Addition of the specific PI 3-K inhibitor LY294002 to the granulosa cell cultures decreased Akt phosphorylation and induced apoptosis in a dose-dependent manner. Taken together, these results demonstrate for the first time the importance and regulation of the PI 3-K survival pathway by XIAP in the control granulosa cell apoptosis.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ACTIVATION OF THE phosphatidylinositol 3-kinase (PI 3-K)/Akt pathway is important for the suppression of apoptosis in many cell systems. First discovered as a lipid kinase that phosphorylates phosphoinositides (PtdIns) at position 3 of the inositol ring, PI 3-K has emerged as an important signal transducing molecule that is activated by diverse growth factor receptors (1). Once activated, PI 3-K phosphorylates Akt (also known as protein kinase B or Rac kinase) in a serine/threonine kinase survival pathway often referred to as the PI 3-K/Akt pathway (2, 3, 4). The phosphorylated Akt, in turn, phosphorylates and attenuates the actions of Bad, a proapoptotic member of the Bcl-2 family (5, 6).

PI 3-K is composed of a catalytic (p110) and a regulatory (p85) subunit (7). The p110 sequence includes a p85-binding region, a Ras-binding domain, and a catalytic core (8, 9, 10). Similarly, the p85 sequence includes an N-terminal Src homology 3 (SH3) domain, a Bcr homologous region flanked by two proline-rich regions, and two SH2 domains separated by an inter-SH2 region (8, 11, 12). It has been shown that the association of p110 with the GTP-binding protein Ras following ligand-receptor binding results in PI 3-K activation (13, 14). PI 3-K activation is also facilitated by the association of p85 with p110 (15) and the recruitment of the p85:p110 dimer by activated protein tyrosine kinase (16).

The inhibitor of apoptosis proteins (IAPs) is a family of intracellular antiapoptotic proteins that were first identified in baculovirus. They include X-linked IAP (XIAP and cIAP-3), human IAP-1 (HIAP-1 and cIAP-2), human IAP-2 (HIAP-2 and cIAP-1), neuronal IAP (NAIP), and survivin (17, 18). IAPs are characterized by the presence of a caspase recruitment domain and an N-terminal baculovirus inhibitor of apoptosis repeat motif, which are necessary for biological activity. With the exception of NIAP and survivin, the IAPs also contain a C-terminal ring-zinc finger domain believed to be required for protein-protein interactions. Only a few reports to date have addressed the mechanisms of action of these antiapoptotic proteins. XIAP has been shown to be a direct inhibitor of caspase-3 and caspase-7 (19) and also to modulate the Bax/cytochrome c pathway by inhibiting caspase-9 (20). Overexpression of XIAP has been shown to protect Chinese hamster ovary (CHO) and Rat-1 cells from menadione or growth factor withdrawal-mediated apoptosis (18) and from apoptosis in HeLa cells induced by transient transfection with interleukin-1ß-converting enzyme (21) as well as suppress apoptosis induced by Sindbis virus (22).

The presence of gonadotropin during follicular development is critical for the selection and survival of the growing follicles (see Ref. 23 for a review). We have previously shown that IAP contents in granulosa cells are increased during follicular growth in response to gonadotropin stimulation in vivo and that gonadotropin withdrawal resulted in decreased granulosa cell IAP expression and apoptosis (24). However, the mechanism(s) by which gonadotropin increased granulosa cell XIAP level and suppressed apoptosis is not known. Moreover, although both PI 3-K and IAPs are well established cell survival intermediates, if and how they interact to determine the fate of the granulosa cells (survival vs. apoptosis) has not been investigated. The objective of the present study was to address this question and to determine how XIAP block programmed cell death during follicular development.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents
Equine CG (eCG), normal rabbit serum (NRS), Hoechst 33248, and LY294002 were supplied by Sigma (St. Louis, MO). RPMI 1640 and FBS were purchased from Life Technologies, Inc. (Burlington, Canada). p85 PI-3K antibody was a gift from Dr. J. Liu (Loeb Health Medical Research Institute, Ottawa, Canada). The anti-eCG antiserum was produced in our laboratory as previously reported (25). Rabbit anti-PhosphoPlus Akt (Ser473) antibody for Western blot and sheep anti-Phospho-Akt (Ser473-MN) antibody for immunohistochemistry were obtained from New England Biolabs, Inc. (Mississauga, Canada) and Upstate Biotechnology, Inc. (Lake Placid, NY), respectively. The Vectastain ABC kit for sheep IgG, blocking kit, fluorescein-avidin D, and Vectashield were purchased from Vector Laboratories, Inc. (Burlingame, CA). Common antibody diluent was supplied by BioGenex Laboratories, Inc. (San Ramon, CA). Polyclonal rabbit antihuman XIAP antibody, adenoviral XIAP sense and antisense full-length complementary DNA (cDNA) and lacZ were provided by Dr. Eric LaCasse (ApoptoGen, Inc., Ottawa, Canada).

Animal preparation
Immature (23–24 days of age) female Sprague Dawley rats (50–60 g; Charles River Laboratories, Inc. Canada, Montréal, Canada) were injected with eCG (15 IU, ip) or saline (0.9% NaCl) and 24 h later, with 100 µl of either NRS (saline and eCG groups) or anti-eCG antiserum (anti-eCG groups). Animals were killed 24 h after NRS or antiserum injection. Ovaries were excised and fixed in 10% formalin for XIAP immunohistochemistry and in situ terminal deoxynucleotidyl transferase-mediated deoxy-UTP-biotin end labeling (TUNEL) of apoptotic cells. In addition, granulosa cells from each group of animals were harvested by follicle puncture as previously described (25). The animals were fed Prolab RMH4018 (Agway, Inc., Syracuse, NY) and water ad libitum. A 14-h light, 10-h dark cycle was maintained, with light cycle initiated at 0600 h.

Cell culture
Granulosa cells (1 x 106), isolated 24 h after eCG injection (15 IU, sc), were cultured in RPMI 1640 containing 10% FBS, 1% nonessential amino acids, 0.5% streptomycin-penicillin, and 0.25% fungizone for 48 at 37 C in an atmosphere of 5% CO2. For XIAP sense and antisense adenoviral infections, the spent medium was discarded, and 0.5 ml fresh 10% FBS medium containing sense XIAP adenovirus [multiplicity of infection (MOI), 0, 1, 2.5, and 5] or antisense XIAP (MOI, 0, 10, 20, and 40). lacZ adenoviral vector was used as the control and was also used in combination with XIAP sense and antisense DNA adenovirals to attain a final viral concentration with MOI of 5 and 40, respectively. The cells were incubated with adenoviral vectors for 1 h with frequent shaking to ensure maximal infection and then cultured in 2 ml FBS-free medium for 48 h. At the end of the culture period, both floating cells and attached cells [recovered by trypsin treatment (0.05% trypsin and 0.53 mM EDTA, 37 C for 3–5 min)] were pooled and centrifuged (1900 x g, 5 min). For protein extraction, cell pellets were resuspended in a lysis buffer (PBS, pH 7.4) containing NaCl (150 mM), SDS (0.1%), sodium deoxycholate (0.5%), Nonidet P-40 (1%), and the protease inhibitor phenylmethylsulfonylfluoride (1 mM).

Immunohistochemistry
Ovarian tissues sections were deparaffinized in xylene and rehydrated through a graded series of alcohol. Immunohistochemistry was performed using a Dakko IHC kit (Dakko Diagnostics Canada, Inc., Mississauga, Canada) with slight modification to the manufacturer’s procedure. Briefly, sections were blocked for 5 min with blocking solution, washed with PBS, and incubated with polyclonal antihuman XIAP antibody (1:50 dilution, room temperature, 1 h). Sections were washed briefly with PBS and incubated for 30 min with a secondary fluorescent antirabbit IgG-FITC antibody, washed again with PBS, and mounted. For phospho-Akt immunohistochemistry, antigens were retrieved by heating the sections with microwave in citrate buffer (0.01 M, pH 6.0) for 20 min (four times, 5 min each time). The sections were then blocked with 1.5% normal serum containing avidin (30 min, room temperature), incubated with sheep anti-phospho-AKT1 antibody (1:250, 1 h at room temperature or overnight at 4 C), washed with PBS (three times for 5 min each time), and incubated with a biotinylated secondary antibody (1:100 in PBS containing 1.5% normal serum; 30 min at room temperature). They were again washed with PBS (three times, 5 min each time), incubated with fluorescein-avidin D (25 µg/ml; 30 min), and mounted for fluorescence imaging.

In situ TUNEL
In situ TUNEL was carried out on ovarian sections and cultured granulosa cells using a TUNEL kit (Roche, Laval, Canada) in accordance with manufacturer’s instructions. At the end of granulosa cell culture period, floating cells were collected by aspiration, and cells attached to the growth surface were subjected to trypsin treatment (0.05% trypsin and 0.53 mM EDTA; 3–5 min, 37 C). The two cell fractions (floating and attached cells) were combined, and an aliquot of this cell mixture was fixed on a microscope slide. At least a total of 200 cells in a randomly selected area were counted for each experimental group. The counter was blinded and was not aware of treatment, so as to avoid experimental bias.

Protein extraction and Western analysis
Cells were sonicated in the lysis buffer (10 sec), and the sonicates were centrifuged (12,000 x g, 20 min, 4 C) to remove insoluble material. Supernatant was recovered and stored at -20 C until further processing. Protein content was determined with a DC protein assay (Bio-Rad Laboratories, Inc., Richmond, CA). Protein extracts were heated (3 min, 94 C), resolved by 10% SDS-PAGE, and electrotransferred to nitrocellulose membranes (15 V, 30 min). The membranes were first stained with SYPRO Ruby protein gel stain (Molecular Probes, Inc., Cedarlane, CA) to test whether the protein loading was constant among samples. Total protein stains were quantitated densitometrically. The membranes were then blocked in PBS containing 5% milk powder (room temperature, 2 h) and incubated (room temperature, 2 h) with antibody for XIAP (1:2500), Akt (1:1000), or Phospho-Akt (1:1000) and subsequently with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000, room temperature, 45 min). Peroxidase activity was visualized with the enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Arlington Heights, IL) according to the manufacturer’s instructions. The content of the protein of interest was likewise scanned and determined by dividing its signal intensity by that of the corresponding total protein to correct for any loading differences between lanes.

Statistical analysis
Results are expressed as the mean ± SEM of four experiments. Statistical analysis were carried out by one-way ANOVA (PRISM software version 2.0, GraphPad Software, Inc., San Diego, CA). Significant differences between treatment groups were determined by Tukey’s test. Statistical significance was inferred at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Gonadotropin increases XIAP protein levels and activates the PI 3-K/Akt pathway in vivo
To examine the regulation of XIAP expression and the activation of the PI 3-K pathway in granulosa cells after gonadotropin stimulation, immature rats injected with eCG and 24 h later with anti-eCG or normal rabbit serum (control) were killed 48 h after the gonadotropin treatment (Figs. 1Go and 2Go). Immunohistochemical examination of ovarian sections from eCG-treated rats revealed high Xiap and phospho-Akt immunoreactivity as well as low TUNEL positivity in granulosa cells whereas the opposite was true in sections from the eCG- plus anti-eCG-treated group (Fig. 1Go). A similar pattern of Xiap and phospho-Akt immunosignals was observed in the thecal layer, although their intensities were considerably higher. Western blot analysis of granulosa cell extracts indicates that whereas gonadotropin treatment in vivo increased granulosa cell XIAP (P < 0.05) and phospho-Akt (P < 0.05) contents, withdrawal of gonadotropin support with anti-eCG antibody administration (eCG and anti-eCG) resulted in decreases in these parameters to levels observed in the saline group and induced apoptosis (P < 0.05; Fig. 2Go). Likewise, ovarian weight was significantly increased in the eCG group (P < 0.05), a phenomenon effectively attenuated by gonadotropin withdrawal. Total Akt protein content, however, was not significantly affected by any of the treatments (Fig. 2Go).



View larger version (73K):
[in this window]
[in a new window]
 
Figure 1. Immunolocalization of XIAP and phospho-Akt and TUNEL labeling in the rat ovary. Immature rats were treated with saline (48 h), eCG (48 h), or eCG plus anti-eCG [eCG (24 h) + anti-eCG (24 h)] as described in Materials and Methods. Ovaries were collected, fixed in 10% formalin for 24 h, paraffin-embedded, and sectioned for immunohistochemical and TUNEL analyses. The negative control (NEG) indicates signals observed when the primary antibody for XIAP and phospho-Akt was replaced with normal rabbit IgG and normal sheep IgG, respectively, or when the terminal transferase in the TUNEL assay was omitted. HEMA, Hematoxylin staining.

 


View larger version (27K):
[in this window]
[in a new window]
 
Figure 2. Effect of eCG administration and withdrawal on granulosa cell XIAP, phospho-Akt, total Akt contents, apoptosis, and ovarian weight in vivo. Immature rats were treated with saline (48 h), eCG (48 h), and eCG plus anti-eCG [eCG (24 h) + anti-eCG (24 h)]. Granulosa cells were collected by follicle puncture and were lysed in lysis buffer for XIAP, phospho-Akt, and Akt Western analysis (A) or fixed for TUNEL measurements (B). Densitometric analysis (A), ovarian weight, and percent apoptosis (B) values are the mean ± SEM of four independent experiments. Columns with an asterisk are significantly different from the other bars (P < 0.05).

 
Antisense XIAP reduces phospho-Akt content and induces apoptosis
To determine whether the increase in granulosa cell phospho-Akt content following eCG treatment in vivo is due to the activation of the PI-3K/Akt pathway by XIAP, granulosa cells from eCG-primed rats were infected for 48 h with different concentrations of an adenovirus containing a XIAP antisense cDNA (Fig. 3Go). Down-regulation of XIAP by antisense expression reduced phospho-Akt content (P < 0.05) and increased apoptosis (P < 0.05) in a concentration- dependent manner. At a MOI of 40, adenoviral XIAP antisense significantly decreased the levels of both XIAP (P < 0.05) and phospho-Akt (P < 0.05) by 38%. Total Akt content remained constant throughout the experiment (Fig. 3Go).



View larger version (47K):
[in this window]
[in a new window]
 
Figure 3. Down-regulation of granulosa cell XIAP decreased phospho-Akt content and induced apoptosis in vitro. One million granulosa cells were plated in RPMI and 10% FBS for 24 h, infected with adenoviral antisense XIAP and lacZ vector (control) for 48 h, as described in Materials and Methods, and collected for Western analysis and TUNEL measurement. Densitometric and apoptosis data are the mean ± SEM of four independent experiments. *, P < 0.05 compared with lacZ control.

 
XIAP overexpression increases Akt phosphorylation
To further characterize the relationship between XIAP and Akt phosphorylation in the granulosa cells, the influence of XIAP overexpression on phospho-Akt content was studied, using a sense XIAP adenovirus (Fig. 4Go). Infection of granulosa cells with increasing concentrations of adenoviral XIAP sense cDNA resulted in concentration-dependent increases not only in XIAP content but also in phospho-Akt levels. Under these conditions, no differences in total Akt protein levels were detected between experimental groups, and the incidence of apoptosis remained low (Fig. 4Go).



View larger version (51K):
[in this window]
[in a new window]
 
Figure 4. Overexpression of granulosa cell XIAP increased phospho-Akt, but not Akt, contents. One million granulosa cells were plated in RPMI and 10% FBS for 24 h, infected with adenoviral sense XIAP and lacZ vector (control) for 48 h, as described in Materials and Methods, and were collected for Western analysis and TUNEL measurement. Densitometric and apoptosis data are the mean ± SEM of four independent experiments. *, P < 0.05 compared with lacZ control.

 
Inhibition of PI 3-K induces apoptosis in granulosa cells
The above studies clearly demonstrated that XIAP plays an important role in the regulation of granulosa cell phospho-Akt levels and survival, although the mechanism involved is not clearly understood. An increase in phospho-Akt content may be a consequence of activation of either PI 3-K or integrin-linked kinase (26). To address the question of whether PI 3-K is involved and to demonstrate that this kinase is important for granulosa cell survival, we examined the influence of the PI 3-K inhibitor LY294002 on granulosa cell phospho-Akt content and apoptosis (Fig. 5Go). The presence of LY294002 significantly decreased Akt phosphorylation and increased apoptosis in a dose-dependent manner (P < 0.05), but had no effect on total Akt content (Fig. 5Go).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 5. Effect of LY294002 on granulosa cell phospho-Akt content and apoptosis in vitro. One million granulosa cells were plated in RPMI and 10% FBS for 24 h before the addition of different concentrations of LY294002. Granulosa cells were cultured for 24 h in RPMI 1640 serum-free medium and collected for Western analysis and TUNEL measurement. Results for apoptosis are the mean ± SEM of three independent experiments. *, P < 0.05 compared with control.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Follicular atresia is a negative and selective degenerative process during follicular growth and development. Although granulosa cell apoptosis has been recognized as the cellular mechanism responsible for follicular atresia, the cross-talk between intracellular proapoptotic and/or antiapoptotic factors is poorly documented. In the present study we investigated the role of the PI 3-K/Akt pathway in granulosa cell survival and its regulation by XIAP. As survival factor-promoted activation of PI 3-K appears to be important in the suppression of apoptosis in many cellular systems, we hypothesized that the regulation of this pathway may be crucial in determining the fate of granulosa cells. Gonadotropins are important survival factors during follicular development. We have previously shown the up-regulation of XIAP in vivo in the presence of gonadotropins (24). In this study we confirmed the relationship between eCG and XIAP and showed that eCG induced Akt phosphorylation/activation in granulosa cells in vivo. In contrast, eCG withdrawal (eCG and anti-eCG treatment) reduced granulosa cell phospho-Akt content, indicating that activation of Akt in vivo is a gonadotropin-dependent process.

Other evidence for the importance of the PI 3-K/Akt pathway in granulosa cell regulation came with the finding that high levels of phosphorylated Akt were present in granulosa cells in vitro under nonstimulated conditions. It is well established that phospho-Akt is the active form of this protein and suppresses cell death activity (see Ref. 27 for a review). The serine-threonine kinase Akt has been shown to be directly phosphorylated and activated by PI 3-K. Activation of Akt, in turn, phosphorylates the proapoptotic protein BAD, a member of the Bcl-2 family (5, 6). The phosphorylated BAD then associates with 14–3-3 protein, preventing BAD from binding with Bcl-xL and thereby promoting cell survival (28). Whereas overexpression of BAD induced rat granulosa cell apoptosis (29), exposure of immature rats to eCG decreased granulosa cell phospho-BAD content (30). Thus, the high levels of phospho-Akt in the eCG-primed granulosa cells observed in the present study may be important in preventing these cells from undergoing apoptosis. This idea is supported by the observation that treatment of granulosa cells with the specific PI 3-K inhibitor LY294002 not only significantly decreased phospho-Akt content, but also increased apoptosis in a concentration-dependent manner. Thus, it is possible that inhibition of the PI 3-K pathway may be a key event in the induction of follicular atresia in vivo, whereas activation of PI 3-K is essential for granulosa cell survival and follicular development.

In the present study we demonstrated that XIAP is involved in the regulation of granulosa cell Akt activity. Whereas eCG treatment in vivo increased granulosa cell XIAP and phospho-Akt contents, these responses were attenuated with gonadotropin withdrawal. Moreover, adenoviral XIAP sense cDNA expression increased granulosa cell phospho-Akt contents, whereas XIAP down-regulation by adenoviral antisense suppressed the phosphorylation of Akt and induced apoptosis. Total Akt levels were not affected by these treatments. Moreover, the relative abundance of XIAP may be a key element in cell fate determination, as it is a potent endogenous inhibitor of caspase-3, -7 (31), and -9 (20, 32). Caspases are a family of aspartate-specific proteases that play an essential role in maintaining cell viability because they are activated in response to a cell death signal. We have previously demonstrated the presence of caspase-3 in granulosa cells of atretic, but not healthy, follicles (33). In the present study it is possible that granulosa cell caspase activation and activity, which were otherwise suppressed by high levels of XIAP, were reactivated when this cell survival protein was down-regulated after antisense expression, thus leading to increased apoptosis. Furthermore, it has been reported that activation of Akt results in procaspase-9 phosphorylation and blockade of the caspase cascade (34), although others have demonstrated that the Akt phosphorylation site found in human caspase-9 was not present in mouse caspase-9 (35). The role of Akt activation in the regulation of granulosa cell survival remains to be elucidated.

The precise mechanism(s) involved in the control of PI 3-K activity by XIAP is not known, and different candidates may be involved. Phosphoinositide-dependent kinase has been shown to be responsible for Akt phosphorylation at the threonine 308 position (36), although this phosphorylation alone was not sufficient for maximal AKT activation, which also required serine 473 phosphorylation in a PtdIns(3, 4, 5)P3 (the product of PI 3-K)-dependent manner. Recently, it has been shown that integrin-linked kinase (ILK; a serine and threonine protein kinase) may directly phosphorylate Akt on Ser473 in vitro (26). On the other hand, as these cellular processes are regulated by both protein tyrosine kinases and protein tyrosine phosphatases, it is also possible that XIAP may regulate phosphatases known to decrease PI 3-K activity. Recombinant PTEN (a tumor suppressor protein and a phospholipid phosphatase) is capable of dephosphorylating both phosphotyrosine and phosphothreonine as well as the product of PI 3-K [PtdIns (3, 4, 5)P3] (37, 38). A recent study demonstrated high ILK activity and Akt phosphorylation in PTEN-mutant prostate cancer cells and that PTEN wild-type transfection suppressed ILK activity and Akt activation (39). As ILK is sensitive to and activated by high levels of PtdIns(3, 4, 5)P3 (26), mutation in the PTEN gene led to PtdIns(3, 4, 5)P3 accumulation and ILK activation. Another possible regulatory protein of PI 3-K is the Src homology 2-containing protein tyrosine phosphatase 1, which functions by direct association with its p85 subunit (40). However, which of these kinases and/or phosphatases are indeed putative candidates involved in the regulation of the phosphorylated (activated) status of Akt and survival in granulosa cells by XIAP remains to be determined.

In conclusion, the results of the present study demonstrate that the PI 3-K/Akt pathway has an important regulatory function in granulosa cells during follicular development. The activation of this survival pathway in granulosa cells is dependent on gonadotropin support and may involve an XIAP-mediated increase in phospho-Akt content.


    Acknowledgments
 
We thank Dr. Eric LaCasse (ApoptoGen, Inc., Ottawa, Canada) for providing the XIAP antibody as well as the adenoviral lacZ, XIAP sense, and antisense cDNAs used in the present studies.


    Footnotes
 
1 This work was been supported by a grant from the Canadian Institutes of Health Research (MOP-10369) and Canadian Institutes of Health Research postdoctoral fellowships (to E.A.). Back

2 Current address: Département de Chimie-Biologie, Section Biologie Médicale, Université du Québec à Trois-Rivières, 3351 boulevard des Forges, C.P. 500, Trois-Rivières, Québec, Canada G9A 5H7. Back

Received October 19, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Panayotou G, Waterfield MD 1993 The assembly of signalling complexes by receptor tyrosine kinases. BioEssays 15:171–177[CrossRef][Medline]
  2. Bellacosa A, de FD, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V 1995 Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64:280–285[Medline]
  3. Coffer PJ, Woodgett JR 1991 Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C. Eur J Biochem 201:475–481[Medline]
  4. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA 1991 Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88:4171–4175[Abstract/Free Full Text]
  5. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241[CrossRef][Medline]
  6. del PL, Gonzalez-Garcia M, Page C, Herrera R, Nunez G 1997 Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687–689[Abstract/Free Full Text]
  7. Woscholski R, Dhand R, Fry MJ, Waterfield MD, Parker PJ 1994 Biochemical characterization of the free catalytic p110{alpha} and the complexed heterodimeric p110{alpha}.p85{alpha} forms of the mammalian phosphatidylinositol 3-kinase. J Biol Chem 269:25067–25072[Abstract/Free Full Text]
  8. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD 1994 PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J 13:511–521[Medline]
  9. Leevers SJ, Weinkove D, MacDougall LK, Hafen E, Waterfield MD 1996 The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J 15:6584–6594[Medline]
  10. Zvelebil MJ, MacDougall L, Leevers S, Volinia S, Vanhaesebroeck B, Gout I, Panayotou G, Domin J, Stein R, Pages F 1996 Structural and functional diversity of phosphoinositide 3-kinases. Philos Trans R Soc Lond B Biol Sci 351:217–223[Medline]
  11. Holt KH, Olson L, Moye-Rowley WS, Pessin JE 1994 Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits. Mol Cell Biol 14:42–49[Abstract/Free Full Text]
  12. Klippel A, Escobedo JA, Hirano M, Williams LT 1994 The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol 14:2675–2685[Abstract/Free Full Text]
  13. Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana P, Downward J, Parker PJ 1994 The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 4:798–806[CrossRef][Medline]
  14. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J 1997 Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467[CrossRef][Medline]
  15. Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F, Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N 1991 Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 65:91–104[CrossRef][Medline]
  16. Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J 1991 Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65:83–90[CrossRef][Medline]
  17. Ambrosini G, Adida C, Altieri DC 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921[CrossRef][Medline]
  18. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG 1996 Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349–353[CrossRef][Medline]
  19. Deveraux QL, Takahashi R, Salvesen GS, Reed JC 1997 X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300–304[CrossRef][Medline]
  20. Deveraux QL, Roy N, Stennicke HR, Van AT, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC 1998 IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215–2223[CrossRef][Medline]
  21. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL 1996 Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93:4974–4978[Abstract/Free Full Text]
  22. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van DJ, Gilfillan MC, Shiels H, Hardwick JM, Thompson CB 1996 A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J 15:2685–2694[Medline]
  23. Asselin E, Xiao CW, Wang YF, Tsang BK 2000 Mammalian follicular development and atresia: role of apoptosis. Biol Signals Recept 9:87–95[CrossRef][Medline]
  24. Li J, Kim JM, Liston P, Li M, Miyazaki T, Mackenzie AE, Korneluk RG, Tsang BK 1998 Expression of inhibitor of apoptosis proteins (IAPs) in rat granulosa cells during ovarian follicular development and atresia. Endocrinology 139:1321–1328[Abstract/Free Full Text]
  25. Kim JM, Boone DL, Auyeung A, Tsang BK 1998 Granulosa cell apoptosis induced at the penultimate stage of follicular development is associated with increased levels of Fas and Fas ligand in the rat ovary. Biol Reprod 58:1170–1176[Abstract/Free Full Text]
  26. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S 1998 Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95:11211–11216[Abstract/Free Full Text]
  27. Kandel ES, Hay N 1999 The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253:210–229[CrossRef][Medline]
  28. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ 1996 Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3-3 not BCL-X(L). Cell 87:619–628[CrossRef][Medline]
  29. Gebauer G, Peter AT, Onesime D, Dhanasekaran N 1999 Apoptosis of ovarian granulosa cells: correlation with the reduced activity of ERK-signaling module. J Cell Biochem 75:547–554[CrossRef][Medline]
  30. Kaipia A, Hsu SY, Hsueh AJ 1997 Expression and function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated death promoter (BAD) in rat ovary. Endocrinology 138:5497–5504[Abstract/Free Full Text]
  31. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC 1998 A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273:7787–7790[Abstract/Free Full Text]
  32. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC 1999 Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 18:5242–5251[CrossRef][Medline]
  33. Boone DL, Tsang BK 1998 Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression. Biol Reprod 58:1533–1539[Abstract/Free Full Text]
  34. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC 1998 Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321[Abstract/Free Full Text]
  35. Fujita E, Jinbo A, Matuzaki H, Konishi H, Kikkawa U, Momoi T 1999 Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun 264:550–555[CrossRef][Medline]
  36. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, Bownes M 1997 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7:776–789[CrossRef][Medline]
  37. Maehama T, Dixon JE 1998 The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378[Abstract/Free Full Text]
  38. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK 1997 P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052–9057[Abstract/Free Full Text]
  39. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S 2000 Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97:3207–3212[Abstract/Free Full Text]
  40. Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen SH 1998 SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 273:3687–3694[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
K. M. Aird, X. Ding, A. Baras, J. Wei, M. A. Morse, T. Clay, H. K. Lyerly, and G. R. Devi
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
Mol. Cancer Ther., January 1, 2008; 7(1): 38 - 47.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Wang and B. K Tsang
Nodal signalling and apoptosis
Reproduction, May 1, 2007; 133(5): 847 - 853.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Wang, J.-Y. Jiang, C. Zhu, C. Peng, and B. K. Tsang
Role and Regulation of Nodal/Activin Receptor-Like Kinase 7 Signaling Pathway in the Control of Ovarian Follicular Atresia
Mol. Endocrinol., October 1, 2006; 20(10): 2469 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Orisaka, S. Orisaka, J.-Y. Jiang, J. Craig, Y. Wang, F. Kotsuji, and B. K. Tsang
Growth Differentiation Factor 9 Is Antiapoptotic during Follicular Development from Preantral to Early Antral Stage
Mol. Endocrinol., October 1, 2006; 20(10): 2456 - 2468.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Z. Spaczynski, J. L. Tilly, A. Mansour, and A. J. Duleba
Insulin and insulin-like growth factors inhibit and luteinizing hormone augments ovarian theca-interstitial cell apoptosis
Mol. Hum. Reprod., May 1, 2005; 11(5): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. R. Hussein
Apoptosis in the ovary: molecular mechanisms
Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. E. Thompson, E. Asselin, A. Branch, J. K. Stiles, P. Sutovsky, L. Lai, G.-S. Im, R. S. Prather, S. C. Isom, E. Rucker III, et al.
Regulation of Prohibitin Expression During Follicular Development and Atresia in the Mammalian Ovary
Biol Reprod, July 1, 2004; 71(1): 282 - 290.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Amantana, C. A. London, P. L. Iversen, and G. R. Devi
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells
Mol. Cancer Ther., June 1, 2004; 3(6): 699 - 707.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. R. Lareu, M. D. Lacher, C. K. Bradley, R. Sridaran, R. R. Friis, and A. M. Dharmarajan
Regulated Expression of Inhibitor of Apoptosis Protein 3 in the Rat Corpus Luteum
Biol Reprod, June 1, 2003; 68(6): 2232 - 2240.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Wang, P. U. Rippstein, and B. K. Tsang
Role and Gonadotrophic Regulation of X-Linked Inhibitor of Apoptosis Protein Expression During Rat Ovarian Follicular Development In Vitro
Biol Reprod, February 1, 2003; 68(2): 610 - 619.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Wu Xiao, E. Asselin, and B. K. Tsang
Nuclear Factor {kappa}B-Mediated Induction of Flice-Like Inhibitory Protein Prevents Tumor Necrosis Factor {alpha}-Induced Apoptosis in Rat Granulosa Cells
Biol Reprod, August 1, 2002; 67(2): 436 - 441.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Wang, S. Chan, and B. K. Tsang
Involvement of Inhibitory Nuclear Factor-{kappa}B (NF{kappa}B)-Independent NF{kappa}B Activation in the Gonadotropic Regulation of X-Linked Inhibitor of Apoptosis Expression during Ovarian Follicular Development in Vitro
Endocrinology, July 1, 2002; 143(7): 2732 - 2740.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Wang, E. Asselin, and B. K. Tsang
Involvement of Transforming Growth Factor {alpha} in the Regulation of Rat Ovarian X-Linked Inhibitor of Apoptosis Protein Expression and Follicular Growth by Follicle-Stimulating Hormone
Biol Reprod, June 1, 2002; 66(6): 1672 - 1680.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asselin, E.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asselin, E.
Right arrow Articles by Tsang, B. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals